跳至主要内容
临床试验/CTRI/2020/07/026371
CTRI/2020/07/026371已完成3 期

A clinical study to evaluate the effect of AYUSH medicines in the management of COVID-19

Sriveda Sattva Private Limited Sri Sri Tattva0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Age limit â?? 20 to 55 years, both Male &Female
  • 2. Uncomplicated cases of COVID19 patients on Allopathic medication of stage 1 and stage 2
  • 3. Patients whom ventilator support is not required
  • 4. Patients with no associated comorbidities
  • 5.patientswillingtogivetheirconsenttoparticipateintheclinicaltrial

排除标准

  • 1. COVID-19 positive patients above 55 years of age & below 20years
  • 2. Patients with associated comorbidities like hypertension, type 2 or type 1 diabetes or chronic or acute renal failure or pre -existing cardiac conditions.
  • 3. Patients on immuno-suppression therapy
  • 4. Pregnant Women or lactating mothers

研究者

发起方
Sriveda Sattva Private Limited Sri Sri Tattva

相似试验